People reported having frequent bad dreams at the beginning of the study were twice as likely to develop Parkinson’s compared with those who had them less than once a week.
About 1 in 300 people in the general population carry the Tay-Sachs disease gene.
Ray Kachatorian/Stone via Getty Images
Tay-Sachs is a rare and fatal neurodegerative disorder that most commonly affects children. Researchers have developed the first Tay-Sachs treatment to reach clinical trials.
Dementia patients are often the perpetrators and often the victims of abuse. Research also shows that a medical history of head injury can more than double the risk of developing Alzheimer’s disease in some populations, even after many years.
(Shutterstock)
From aggressive patients with Alzheimer’s to frustrated caregivers, dementia is increasingly entwined with violence in private homes and residential facilities.
Researchers are cautiously optimistic about a new treatment for Parkinson’s.
sfam_photo/Shutterstock
Affiris, a biotech company based in Austria, and the Michael J Fox Foundation, have announced the latest results of a vaccine they have been developing to treat Parkinson’s disease. Following the first…
Anthony Hannan, Florey Institute of Neuroscience and Mental Health
The human brain is the most complex and extraordinary structure in the known universe. And while there are many awe-inspiring facets of the brain, I will focus here on “neuroplasticity”, a term that has…